Skip to main content

Table 5 Antibiotics resistance patterns of non- Enterobacteriaceae group at HUCSH, Southern Ethiopia

From: The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years’ retrospective study

Antibiotics

Pseudomonas spp (47)

Acinetobacter spp (18)

N. gonorrhoea (3)

N. meningitis (4)

Total

 

R (%)

R (%)

R (%)

R (%)

R (%)

Amp

23(92)

15(88.2)

NR

ND

39(92.9)

Gen

22(55.2)

11(84.6)

NR

ND

33(62.2)

CRP

14(32.6)

9(56.2)

2(100)

2(50)

27(41.5)

CTR

23(67.6)

10(76.9)

2(66.7)

1(100)

38(71.7)

CAZ

10(47.6)

3(75)

1(100)

1(100)

15(55.6)

NOR

3(25)

3(60)

NR

ND

7(41.2)

AUG

24(85.7)

11(78.6)

NR

1(100)

36(83.7)

COT

15(88.2)

10(100)

NR

1(50)

27(93.1)

CAF

14(70)

10(83.3)

NR

2(100)

26(76.5)

MER

2(50)

2(50)

NR

ND

4(50)

TAT

3(100)

2(100)

ND

NR

5(100)

  1. ND-not done, NR-not recommended, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg).